New Market Research Report: GlobalHypertensionDrugs Market 2016-2020

From: Fast Market Research, Inc.
Published: Tue Apr 26 2016

Hypertension, or high blood pressure (BP), develops when there is too much pressure against the inner walls of blood vessels. Depending on the pressure exerted, hypertension can be classified as:

* Systemic hypertension (commonly referred to as hypertension)

PAH, high BP in the arteries that carry blood from the heart to the lungs, occurs when blood vessels narrow, making blood flow difficult. This creates pressure on the heart's right ventricle, which increases in size and becomes weaker due to the excess load, leading to heart failure. The normal pulmonary arterial pressure at rest is 14 mmHg and increases from 25 mmHg to 30 mmHg.
Systemic hypertension occurs when blood vessels that supply oxygenated blood to the body become narrower, creating pressure on the right side of the heart. Hypertension can lead to damaged organs and illnesses such as renal failure (kidney failure), aneurysm, heart failure, stroke, or heart attack. Hypertension is classified into two types:

Full Report Details at

* Primary or essential hypertension: It is defined as high BP with no known cause, and includes around 90%-95% of all hypertension cases
* Secondary hypertension: It is high BP with a known direct cause, including kidney disease, tumors, or birth control pills, and includes 5%-10% of all hypertension cases

Technavio's analysts forecast the global hypertension drugs market to decline at a CAGR of (0.93) % during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global hypertension drugs market for 201652020. To calculate the market size, the report considers the revenue generated from the sales of branded and generic drugs used to treat and prevent hypertension and pulmonary arterial hypertension (PAH).

The market is divided into the following segments based on geography:

* Americas

Technavio's report, Global Hypertension Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

* Actelion Ltd.
* AstraZeneca plc
* Boehringer Ingelheim GmbH
* Daiichi Sankyo Company, Ltd.
* Novartis AG
* Sanofi SA

Other prominent vendors

* Actelion Pharmaceuticals
* Arena Pharmaceuticals
* Asahi Kasei
* Bayer HealthCare
* Bellerophon Therapeutics
* Bial
* CJ HealthCare
* Conatus Pharmaceuticals
* Daiichi Sankyo
* Deka Pharmaceuticals
* Dong-A ST
* Eiger BioPharmaceuticals
* Forest Laboratories
* Gilead Sciences
* HanAll BioPharma
* Hanmi Pharmaceutical
* Johnson & Johnson
* LG Life Sciences

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »